GlassScriptPhysician profile
Nina Kukar
NPI 1174768980
$39,756.52
in general payments reported to CMS, 2019-2025
17 companies · $346 in 2025
The $346 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $7,150 · 2021: $3,541 · 2022: $6,924 · 2023: $892 · 2024: $327 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $864 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $863.61 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $700.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $37,558.26 | 2019-2023 | Repatha |
| Heartflow, INC. | $684.17 | 2021-2025 | Ffrct |
| Abbott Laboratories | $465.23 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $175.08 | 2019-2024 | Farxiga, Wainua |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.70 | 2022-2024 | Jardiance |
| Esperion Therapeutics, INC. | $149.15 | 2021 | |
| Biotronik INC. | $101.32 | 2019 | |
| Merck Sharp & Dohme LLC | $78.02 | 2025 | Verquvo, Capvaxive |
| Lantheus Medical Imaging, INC. | $71.09 | 2019-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $66.66 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $60.21 | 2023-2024 | Inpefa |
| Alnylam Pharmaceuticals INC. | $53.32 | 2024-2025 | Onpattro |
| Bridgebio Pharma, INC. | $49.58 | 2025 | Attruby |
| Endotronix, INC. | $31.19 | 2024 | Cordella Pulomonary Artery Pressure Sensor |
| Abiomed | $22.73 | 2024 | Impella |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $17.58 | 2025 | |
| Philips North America LLC | $17.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nina Kukar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.